Renal Cancer

Mr Christopher Anderson is a Consultant Urological Surgeon with a specialist interest in Renal and Prostate cancer. He has particular expertise in minimally invasive surgical approaches. He was an early adopter of laparoscopy and also an integral member of the team of Urologists who pioneered robotic surgery introducing it to the UK in 2005. He was the first surgeon to perform Laparoscopic Cryotherapy in the UK in 2004 and accrued a large cohort of such patients with long term follow up. He completed his undergraduate training at Stellenbosch University and his postgraduate training at Cape Town University South Africa and commenced a substantive Consultant post at St George's University Hospital in London in 1999. His early training in Laparoscopy and Robotic surgery took him on fellowships to Cleveland Clinic (Ohio), Jackson Memorial Hospital (Miami) and Henry Ford Hospital (Detroit) as well as University Hospital of Leipzig (Germany). In the early years of Laparoscopic development He was a Trainer at Laparoscopic courses in Germany at Aesculap Academy Tuttlingen and Charite Hospital Berlin where he trained numerous UK and European Urologists. He was subsequently a Proctor to many UK Urologists in the field of Robotics. He has numerous peer review publications to his name and is an active clinical researcher in his field. He is a high volume surgeon and has built up a comprehensive tertiary referral Renal Cancer Service at St Georges Hospital. He is a passionate family man with whom he enjoys his musical and sporting interests. Dr Mehran Afshar, PhD, MB BS(Lond), MRCP(UK), PGDip(Onc), is a consultant oncologist at St George's University Hospitals, London, UK, specializing in the management of urological malignancies; he is also the Clinical Lead for Acute Oncology Services and Lead for Undergraduate Education in Oncology. He is an honorary Senior Lecturer at St Georges, University of London. He studied medicine at Barts & The Royal London School of Medicine and Dentistry, London (MBBS 2001), and completed his PhD in urologic oncology at Warwick University, Warwick, UK. Dr Afshar's research interests include big data research, cancer informatics, biomarkers in cancer, and psycho-oncology, focusing on prostate, bladder, kidney, and penile cancers. He believes in a multi-faceted approach to cancer research and the care of the patient with cancer, integrating scientific, holistic, and technological interventions into an overarching therapeutic paradigm. He currently has over 50 publications and international presentations in his specialist fields. A number of his clinical works have achieved national and international acclaim with over 400 press articles in news outlets across 4 continents.